%0 Journal Article
%T Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy ¨C PIPAC-OPC2
%A Bassam Mahdi
%A Claus Fristrup
%A Jon Asmussen
%A Martin Graversen
%A Michael Bau Mortensen
%A Per Pfeiffer
%A S£¿nke Detlefsen
%J Archive of "Pleura and Peritoneum".
%D 2018
%R 10.1515/pp-2018-0108
%X Peritoneal carcinomatosis (PC) is a common endpoint in both gastrointestinal and non-gastrointestinal cancers, and PC is treated as other systemic metastases ¨C unfortunately with disappointing results and considerable side-effects. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) is a new method of applying traditional chemotherapy, and preliminary data indicate that PIPAC is safe, able to stabilize or improve quality of life, and can induce an objectively measurable reduction in disease burden in PC
%K MRI
%K peritoneal carcinomatosis
%K peritoneal regression grading score (PRGS)
%K PIPAC
%K quality of life
%K response evaluation.
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404994/